{"gene":"ZFPM2","run_date":"2026-06-11T09:02:06","timeline":{"discoveries":[{"year":1999,"finding":"FOG-2 (ZFPM2) is a nuclear protein containing eight zinc finger motifs that physically associates with the N-terminal zinc finger of GATA-4 both in vitro and in vivo, and overexpression of FOG-2 represses GATA-4-dependent transcription from multiple cardiac-restricted promoters in NIH 3T3 cells and primary rat cardiomyocytes.","method":"Co-immunoprecipitation, GST pulldown, co-transfection reporter assays in cardiomyocytes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro binding and in vivo co-IP replicated independently in three simultaneous papers (PMID:9927675, PMID:10330188, PMID:9927674) using multiple orthogonal methods","pmids":["9927675","10330188","9927674"],"is_preprint":false},{"year":1999,"finding":"FOG-2 interacts with the co-repressor C-terminal binding protein-2 (CtBP2) via a conserved PIDLS motif, and this interaction is required for repression activity in some contexts (repression of crystal cell production in Drosophila) but is NOT required for FOG-2-mediated repression of GATA4-dependent transcription in mammalian cells.","method":"GST pulldown, co-transfection luciferase reporter assays, site-directed mutagenesis of PIDLS motif","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis of interaction motif combined with functional reporter assays, replicated in PMID:11404479","pmids":["10438528","10801815","11404479"],"is_preprint":false},{"year":2000,"finding":"FOG-2 knockout mice die at midgestation with thin ventricular myocardium, common atrioventricular canal, tetralogy of Fallot malformation, and complete absence of coronary vasculature despite an intact epicardial layer. Transgenic re-expression of FOG-2 specifically in cardiomyocytes rescues the coronary vascular phenotype, demonstrating that FOG-2 function in myocardium is required and sufficient for coronary vessel development.","method":"Germline knockout mouse, transgenic rescue with cardiomyocyte-specific re-expression, histology, ICAM-2/FLK-1 marker analysis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — germline KO with defined phenotype plus transgenic rescue experiment in a single rigorous study","pmids":["10892744"],"is_preprint":false},{"year":2000,"finding":"FOG-2 (Zfpm2) deficiency in mice produces a syndrome of tricuspid atresia including absent tricuspid valve, large atrial septal defect, ventricular septal defect, elongated left ventricular outflow tract, and hypoplasia of the compact zone of the left ventricle, establishing Zfpm2 as required for normal cardiac looping and septation.","method":"Targeted mutagenesis (gene knockout), histological and morphological analysis of embryos","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — targeted KO with defined cardiac phenotype, independently confirmed in PMID:10892744","pmids":["10888889"],"is_preprint":false},{"year":2000,"finding":"A conserved N-terminal domain of FOG-2 (amino acids 1–247) is both necessary and sufficient to repress GATA4-dependent transcription, independent of CtBP2 interaction. Zinc fingers 1 and 6 of FOG-2 each interact with evolutionarily conserved motifs in the N-terminal zinc finger of GATA proteins. A nuclear localization signal (RKRRK, aa 736–740) is required for nuclear targeting of FOG-2.","method":"Deletion mutagenesis, co-transfection reporter assays, GST pulldown with GATA protein fragments, site-directed mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstitution-style domain mapping with mutagenesis, single lab but multiple orthogonal methods","pmids":["10801815"],"is_preprint":false},{"year":2002,"finding":"GATA4 and FOG2 physical interaction is required for normal gonadal differentiation and Sry expression. XY mice homozygous for Fog2 null or a Gata4 knockin that abrogates FOG co-factor binding show severely reduced Sry transcript levels at E11.5, loss of Sox9/Mis/Dhh expression, and ectopic Wnt4 expression, while Wt1 and Sf1 are unaffected.","method":"Genetic epistasis using Fog2-null and Gata4(ki/ki) mouse models, quantitative RT-PCR, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genetic models with orthogonal molecular readouts establish pathway position","pmids":["12223418"],"is_preprint":false},{"year":2001,"finding":"FOG-2 represses crystal cell production in Drosophila, but a FOG-2 mutant lacking the conserved CtBP-binding motif (PIDLS) fails to repress crystal cell lineage, indicating that CtBP recruitment is required for FOG-2 function in blood but not in cardiac or eye contexts, revealing context-dependent repression mechanisms.","method":"Transgenic Drosophila overexpression, CtBP-binding mutant analysis, cell lineage counting","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined phenotypic readout with mutagenesis in a model organism, single lab","pmids":["11404479"],"is_preprint":false},{"year":2002,"finding":"FOG-2 represses GATA-4-mediated transactivation of the Müllerian-inhibiting substance (MIS) gene in granulosa cells, and its loss of expression in fetal Sertoli cells accompanies testicular cord formation, suggesting a role in suppressing MIS in the developing ovary.","method":"In vitro transfection reporter assays in granulosa cells, Northern blot, RNA in situ hybridization, immunohistochemistry","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — transfection assay plus expression analysis, single lab, two orthogonal approaches","pmids":["12606418"],"is_preprint":false},{"year":2002,"finding":"FOG-1 and FOG-2 differentially repress GATA-dependent promoter activities of multiple gonadal genes (MIS, inhibin alpha, P450 aromatase, StAR) in testicular cells in a promoter- and cell-type-dependent manner.","method":"Co-transfection luciferase reporter assays in testicular cell lines","journal":"Endocrinology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — transfection assays across multiple promoters, single lab","pmids":["12239108"],"is_preprint":false},{"year":2002,"finding":"Liganded RXRα interacts directly with GATA-4 (via its DNA-binding domain to the second zinc finger of GATA-4) and with FOG-2 in a 9-cis-RA-dependent manner. Co-expression of liganded RXRα and FOG-2 results in additive repression of GATA-4 activity in ventricular myocytes, revealing a retinoid-dependent mechanism linking RXRα to the FOG-2 co-repressor complex.","method":"GST pulldown, co-transfection reporter assays in cardiomyocytes, ligand-dependent interaction assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — GST pulldown plus functional reporter assay, single lab, two orthogonal methods","pmids":["12480945"],"is_preprint":false},{"year":2003,"finding":"FOG-2 regulates Kv4.2 potassium channel gene transcription by differentially modulating GATA-dependent activation: in cardiac myocytes FOG-2 suppresses GATA-induced transcription through a GATA-FOG complex, whereas in PC12 cells FOG-2 enhances GATA activity through a GATA-independent mechanism.","method":"Transient transfection with Kv4.2 promoter-luciferase reporters, use of GATA mutants unable to bind FOG, in cardiac myocytes and PC12 cells","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional reporter assays with GATA interaction-deficient mutants establishing mechanism, single lab","pmids":["14613857"],"is_preprint":false},{"year":2004,"finding":"FOG-2 physically interacts with the transcriptional coactivator p300, competes with GATA-4 for p300 binding, reduces the GATA-4/p300 interaction, and represses phenylephrine-induced hypertrophic responses (myofibrillar organization, cell size increase, hypertrophy-associated gene transcription) in cardiac myocytes. In COS7 cells with disrupted endogenous p300, FOG-2 cannot repress baseline GATA-4 activity but can repress p300-mediated GATA-4 enhancement.","method":"Co-immunoprecipitation/western blot, co-transfection reporter assays, phenylephrine-induced hypertrophy model in cardiomyocytes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP plus functional cellular phenotype with mechanistic dissection, single lab but multiple orthogonal methods","pmids":["15220332"],"is_preprint":false},{"year":2005,"finding":"Fog2 (Zfpm2) is required for normal diaphragm and lung development; an ENU-induced splice donor mutation in mice produces pulmonary hypoplasia and abnormal diaphragmatic development, and a de novo FOG2 premature stop codon was identified in a human infant with severe bilateral pulmonary hypoplasia and abnormally muscularized diaphragm.","method":"ENU mutagenesis screen in mice, DNA sequencing of splice site and coding sequence, human autopsy case sequencing","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function in mouse model with defined phenotype corroborated by human genetic evidence","pmids":["16103912"],"is_preprint":false},{"year":2006,"finding":"FOG-2 attenuates endothelial-to-mesenchymal transformation (EMT) in developing endocardial cushions; FOG-2-deficient mice show a 78% increase in outflow tract cushion EMT and 35% increase in atrioventricular cushion EMT in collagen gel invasion assays, without differences in mesenchymal cell proliferation, differentiation, apoptosis, or myocardialization.","method":"FOG-2 knockout mouse model, collagen gel invasion assay for EMT, proliferation/apoptosis/differentiation assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — KO mouse with specific in vitro functional assay and multiple negative controls ruling out alternative mechanisms","pmids":["17274974"],"is_preprint":false},{"year":2007,"finding":"Loss of the FOG-2–GATA4 interaction (via Gata4(ki/ki) or Fog2(-/-)) results in the absence of ovarian development and identifies Dkk1 (a secreted inhibitor of canonical β-catenin signaling) as a target of GATA4-FOG2 repression. Ablation of β-catenin in gonads disrupts female development, and double mutants Gata4(ki/ki);Dkk1(-/-) or Fog2(-/-);Dkk1(-/-) show partial restoration of normal ovarian gene expression.","method":"Genetic epistasis with double mutants (Fog2/Dkk1 and Gata4(ki)/Dkk1), gonad-specific β-catenin conditional knockout, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-mutant genetic epistasis with multiple lines converging on same pathway, rigorous controls","pmids":["18927154"],"is_preprint":false},{"year":2008,"finding":"FOG-2 physically interacts with thyroid hormone receptor-alpha1 (TRα1) and abrogates T3-mediated SERCA2 gene promoter activation. FOG-2 is upregulated in human and murine failing hearts; cardiac-specific FOG-2 overexpression in transgenic mice causes depressed cardiac function, activation of the fetal gene program, and reduced SERCA2 transcript and protein levels.","method":"Co-immunoprecipitation, transgenic mouse overexpression, SERCA2 promoter-reporter assays, T3-treatment experiments in cardiomyocytes","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP establishes physical interaction; transgenic model with functional phenotype; promoter assay defines mechanism; single lab but multiple orthogonal methods","pmids":["18658259"],"is_preprint":false},{"year":2009,"finding":"FOG-2 expression in cardiomyocytes is post-transcriptionally regulated by microRNA-130a, which binds a conserved site in the FOG-2 3′ UTR. Cardiomyocyte-specific transgenic overexpression of miR-130a reduces FOG-2 protein by up to 80% and causes ventricular wall hypoplasia and ventricular septal defects resembling FOG-2 deficiency.","method":"Luciferase 3′ UTR reporter assay, miR-130a knockdown in fibroblasts, transgenic mouse overexpression of miR-130a, western blot","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 / Moderate — 3′ UTR reporter with site mutagenesis, knockdown validation, and in vivo transgenic phenotype; single lab, multiple orthogonal methods","pmids":["19582148"],"is_preprint":false},{"year":2009,"finding":"FOG-2 and its target USH (Drosophila) inhibit PI3K activity by directly binding to p85α, the regulatory subunit of PI3K, interfering with PI3K complex formation, thereby suppressing cell growth. This mechanism is conserved: human FOG2 also binds p85α and suppresses PI3K-dependent growth.","method":"Co-immunoprecipitation of FOG2 with p85α, cell growth assays, genetic epistasis in Drosophila fat body and human cells","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP demonstrating direct protein-protein interaction, functional epistasis in two organisms, rigorous controls","pmids":["20005803"],"is_preprint":false},{"year":2009,"finding":"Early cardiomyocyte-restricted loss of Fog2 recapitulates cardiac and coronary defects of germline knockouts. Later cardiomyocyte-restricted Fog2 loss (Fog2MC) causes severely depressed ventricular function and death at 8–14 weeks with paucity of coronary vessels, myocardial hypoxia, cardiomyocyte apoptosis, and cardiac fibrosis. Ablation of the FOG2–GATA4 interaction produces similar adult phenotypes, and loss of FOG2 or FOG2–GATA4 interaction alters expression of angiogenesis-related genes.","method":"Spatiotemporally regulated conditional Fog2 knockout (Cre-lox), inducible adult-specific Fog2 deletion, Gata4 interaction-domain mutation, echocardiography, histology, gene expression","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple conditional models with defined temporal and spatial specificity, replicated across embryonic and adult contexts in same study","pmids":["19411759"],"is_preprint":false},{"year":2009,"finding":"Cardiac expression of slow skeletal troponin T (Tnnt1) strictly depends on physical interaction between GATA4 and FOG2 in the myocardium of both atria and ventricles, identifying Tnnt1 as a direct transcriptional target of the GATA4-FOG2 complex.","method":"Genetic analysis using Gata4(ki/ki) and Fog2(-/-) mouse models, gene expression analysis","journal":"TheScientificWorldJournal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — genetic epistasis in two mouse models, single lab, limited to expression readout without direct chromatin analysis","pmids":["19578715"],"is_preprint":false},{"year":2011,"finding":"Conditional somatic ablation of Fog2 in gonadal cells causes an early partial block in the male pathway and sex reversal, while GATA4 loss primarily disrupts Dmrt1 expression and testis cord morphogenesis. These experiments reveal non-overlapping essential functions for GATA4 and FOG2 in testis development.","method":"Sf1Cre-mediated conditional knockout of Gata4 and Fog2, gonadal gene expression analysis, histology","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined cellular compartment and multiple molecular readouts, single lab but orthogonal histological and expression methods","pmids":["21385577"],"is_preprint":false},{"year":2012,"finding":"The miR-17-5p and miR-20a members of the miR-17-92 cluster directly target sites in the FOG-2 3′ UTR and post-transcriptionally repress FOG-2 expression. Overexpression of miR-17-92 inhibits embryonic cardiomyocyte proliferation, an effect rescued by FOG-2 re-expression.","method":"Luciferase 3′ UTR reporter assay, RT-PCR, western blot, EdU proliferation assay with FOG-2 rescue in embryonic cardiomyocytes","journal":"Brazilian journal of medical and biological research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — 3′ UTR reporter plus rescue experiment, single lab, two orthogonal methods","pmids":["22267003"],"is_preprint":false},{"year":2012,"finding":"FOG-2 is SUMOylated at four lysine residues (K324, K471, K915, K955). Mutation of SUMOylation sites or de-SUMOylation with SENP-1/SENP-8 results in stronger transcriptional repression activity. Increased SUMOylation (SUMO-1 overexpression or SUMO-1–FOG-2 fusion) abolishes repression of GATA-4-mediated BNP promoter activation. GATA-4 co-expression enhances FOG-2 SUMOylation, and a SUMO-deficient FOG-2 mutant shows increased interaction with GATA-4.","method":"Site-directed mutagenesis of SUMOylation sites, SENP-mediated de-SUMOylation, SUMO-1 overexpression, reporter assays, co-immunoprecipitation","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of PTM sites with functional reporter readout and co-IP, single lab but multiple orthogonal methods","pmids":["23226341"],"is_preprint":false},{"year":2013,"finding":"TGF-β1 activates Akt in glomerular mesangial cells by inducing miR-200b/c, which targets FOG2 (an inhibitor of PI3K activation). FOG2 knockdown by siRNA activates both Akt and ERK through PI3K activation and increases protein content/cell ratio, mimicking hypertrophy. miR-200b/c inhibitors attenuate TGF-β-induced FOG2 decrease and mesangial hypertrophy.","method":"siRNA knockdown of FOG2, miR-200b/c mimic/inhibitor transfection, western blot for PI3K-Akt-ERK pathway, protein content assay in mesangial cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — siRNA loss-of-function with defined PI3K pathway phenotype plus miRNA mimic/inhibitor rescue, single lab, multiple orthogonal methods","pmids":["23788640"],"is_preprint":false},{"year":2014,"finding":"FOG-2 recruits the NuRD (Nucleosome Remodeling and Deacetylase) complex and this interaction is required in vivo for cardiomyocyte proliferation. Mice carrying an R3K5A mutation that disrupts NuRD binding show perinatal lethality, ventricular and atrial septal defects, thin ventricular myocardium, and 31% reduction in cardiomyocyte proliferation. The cell cycle inhibitor Cdkn1a (p21) is upregulated 2-fold, and genetic ablation of Cdkn1a partially rescues left ventricular wall thickness in FOG-2(R3K5A) mice.","method":"Knock-in mouse with NuRD-binding mutation (R3K5A), cardiomyocyte proliferation measurement, Cdkn1a promoter-reporter assay, double mutant rescue (Fog2(R3K5A);Cdkn1a-/-)","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — knock-in mutagenesis of interaction motif, defined cellular phenotype, promoter assay, and genetic rescue experiment in single study","pmids":["25196150"],"is_preprint":false},{"year":2014,"finding":"FOG-2 interacts with AML1 in the AML1-FOG2 fusion protein found in myelodysplasia with t(X;21). AML1-FOG2 represses transcriptional activity of both CBF and GATA1. AML1-FOG2 retains the CtBP-recruiting motif and associates with CtBP in a protein complex, implicating CtBP in AML1-FOG2-mediated transcriptional repression.","method":"Characterization of t(X;21) fusion gene, co-immunoprecipitation of AML1-FOG2 with CtBP, transcriptional reporter assays for CBF and GATA1 activity","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and reporter assays in a disease context, single lab, two orthogonal methods","pmids":["15705784"],"is_preprint":false},{"year":2014,"finding":"Art27 interacts physically with FOG-2, GATA-4, and NKX2.5 (identified by yeast two-hybrid and validated by co-immunoprecipitation) and functions as a co-repressor that down-regulates GATA-4/FOG-2 activity on cardiac-specific promoters (αMHC, ANP, BNP) in cardiomyocytes.","method":"Yeast two-hybrid library screen, co-immunoprecipitation, co-transfection luciferase reporter assays, microarray gene expression in cardiomyocytes","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — yeast two-hybrid confirmed by co-IP plus functional reporter assays, single lab","pmids":["24743694"],"is_preprint":false},{"year":2014,"finding":"Two FOG2 missense mutations (p.S402R and p.R260Q/p.M544I) identified by whole exome sequencing in patients with 46,XY gonadal dysgenesis impair the ability of FOG2 protein to interact with GATA4, as demonstrated by functional interaction assays, providing the first evidence linking FOG2 coding mutations to 46,XY DSD in humans.","method":"Whole exome sequencing, protein-protein interaction functional assays (GST pulldown or equivalent), clinical genetics","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assay of protein-protein interaction for patient variants, single lab","pmids":["24549039"],"is_preprint":false},{"year":2016,"finding":"FOG-2 (Fog2) controls corticothalamic projection neuron (CThPN) molecular differentiation, axonal targeting, and subtype diversity in the neocortex. Loss of Fog2 specifically disrupts differentiation of CThPN subsets specialized in motor function, in part by regulating the expression level of Ctip2 via combinatorial interactions with other molecular controls.","method":"Conditional knockout of Fog2 in CThPN, in situ hybridization, immunohistochemistry, axonal tracing, gene expression analysis","journal":"Neuron","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO with defined neuronal phenotype and molecular target identification, single lab","pmids":["27321927"],"is_preprint":false},{"year":2016,"finding":"Hepatic FOG2 regulates insulin sensitivity and hepatic triglyceride accumulation through PPARα. FOG2 overexpression attenuates insulin signaling in hepatocytes; FOG2 knockdown ameliorates insulin resistance in db/db mice. FOG2 overexpression reduces hepatic TG accumulation via increased PPARα expression; re-expression of PPARα reverses the effects of FOG2 knockdown on insulin sensitivity and hepatic TG. FOG2 liver-specific knockout mice exhibit enhanced insulin sensitivity and elevated hepatic TG, both reversed by Ad-PPARα.","method":"Adenoviral FOG2 overexpression and shRNA knockdown in vivo and in vitro, liver-specific conditional knockout mouse, insulin tolerance tests, hepatic TG measurement, PPARα rescue experiments","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO plus adenoviral gain/loss-of-function in multiple mouse models, PPARα rescue establishes epistatic pathway placement","pmids":["27207553"],"is_preprint":false},{"year":2024,"finding":"FOG2 is significantly upregulated in human atria during heart failure. Cardiomyocyte-specific FOG2 overexpression in mice causes primary spontaneous atrial fibrillation (before structural remodeling) by generating arrhythmia substrate including calcium cycling defects. FOG2 represses TBX5-dependent atrial gene expression by binding a subset of GATA4 and TBX5 co-bound genomic locations, including a conserved enhancer at the Atp2a2 (SERCA2) locus. Atrial rhythm abnormalities from Tbx5 haploinsufficiency are rescued by Zfpm2 haploinsufficiency, establishing FOG2 as antagonizing TBX5 in an atrial gene regulatory network.","method":"Cardiac-specific FOG2 transgenic overexpression, in vivo electrophysiology, cellular electrophysiology, calcium imaging, ChIP/genomic analysis of enhancer activity, genetic epistasis (Tbx5+/-;Zfpm2+/- double mutants), gene expression analysis","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Strong — transgenic mouse model with whole-animal electrophysiology, multiple cellular phenotypes, genomic mechanism, and genetic epistasis rescue in a single study","pmids":["38189150"],"is_preprint":false}],"current_model":"ZFPM2/FOG-2 is a multi-zinc-finger transcriptional co-regulator that physically associates (via zinc fingers 1 and 6) with the N-terminal zinc finger of GATA4/GATA1 to modulate GATA-dependent transcription in a context-dependent manner (repression or activation), recruits co-repressor complexes including NuRD and CtBP, is itself regulated by SUMOylation (which attenuates its repressive activity) and by multiple microRNAs (miR-130a, miR-200b/c, miR-17-92) targeting its 3′ UTR, directly inhibits PI3K activity by binding p85α, interacts with thyroid hormone receptor-α1 to suppress SERCA2 expression, and is required in cardiomyocytes for heart morphogenesis, coronary angiogenesis, adult cardiac rhythm (by antagonizing a TBX5/GATA4 atrial gene regulatory network), and cardiomyocyte proliferation (through NuRD-mediated repression of Cdkn1a/p21), as well as in gonadal somatic cells for Sry induction and male sex determination, and in diaphragm/lung progenitors for normal diaphragm and pulmonary development."},"narrative":{"mechanistic_narrative":"ZFPM2/FOG-2 is a multi-zinc-finger nuclear transcriptional co-regulator that controls organ development and adult tissue homeostasis primarily by binding GATA transcription factors and modulating their activity in a promoter- and cell-type-dependent manner [PMID:9927675, PMID:10330188, PMID:9927674, PMID:10801815, PMID:14613857]. It associates through zinc fingers 1 and 6 with conserved motifs in the N-terminal zinc finger of GATA-4, with an N-terminal domain (aa 1–247) both necessary and sufficient for repression and a defined nuclear localization signal directing nuclear targeting [PMID:10801815]. FOG-2 represses GATA-dependent transcription by recruiting co-repressor machinery — CtBP via a conserved PIDLS motif (required in some lineages but dispensable for cardiac GATA4 repression) and the NuRD nucleosome remodeling/deacetylase complex, the latter being required in cardiomyocytes for proliferation through repression of the cell-cycle inhibitor Cdkn1a/p21 [PMID:10438528, PMID:10801815, PMID:11404479, PMID:25196150]; it can also antagonize GATA4 coactivation by competing with p300 [PMID:15220332]. Its repressive output is tuned by SUMOylation, which attenuates GATA-4 interaction and repression, and its abundance is set post-transcriptionally by 3′UTR-targeting microRNAs including miR-130a and the miR-17-92 cluster [PMID:23226341, PMID:19582148, PMID:22267003]. In the heart, FOG-2 function in myocardium is required for ventricular development, cardiac septation/looping, and coronary vessel formation, and in the adult it antagonizes a TBX5/GATA4 atrial gene regulatory network — including at a SERCA2/Atp2a2 enhancer — to maintain normal atrial rhythm [PMID:10892744, PMID:10888889, PMID:19411759, PMID:38189150]. In gonadal somatic cells the GATA4–FOG2 interaction is required for Sry induction and male sex determination, with human FOG2 coding mutations that disrupt GATA4 binding causing 46,XY gonadal dysgenesis, and FOG-2 is also required for normal diaphragm and lung development, with a human loss-of-function allele linked to pulmonary hypoplasia [PMID:12223418, PMID:24549039, PMID:16103912]. Beyond transcription, FOG-2 directly inhibits PI3K by binding the p85α regulatory subunit, a conserved mechanism that restrains cell growth and influences hepatic insulin sensitivity via PPARα [PMID:20005803, PMID:23788640, PMID:27207553].","teleology":[{"year":1999,"claim":"Established the founding molecular activity — that ZFPM2 is a nuclear zinc-finger protein that physically engages GATA-4 and represses GATA-dependent cardiac transcription, defining it as a GATA co-regulator.","evidence":"Co-IP, GST pulldown and reporter assays in cardiomyocytes, replicated across three simultaneous papers","pmids":["9927675","10330188","9927674"],"confidence":"High","gaps":["Did not resolve which zinc fingers mediate binding","Did not identify the co-repressor machinery responsible for repression"]},{"year":1999,"claim":"Identified a CtBP co-repressor recruitment mechanism via the PIDLS motif and showed it is context-dependent, distinguishing lineage-specific from cardiac repression modes.","evidence":"GST pulldown, reporter assays and PIDLS motif mutagenesis","pmids":["10438528","10801815","11404479"],"confidence":"High","gaps":["Did not explain what co-repressor substitutes for CtBP in cardiac GATA4 repression"]},{"year":2000,"claim":"Mapped the interaction and repression determinants, showing zinc fingers 1 and 6 bind the GATA N-terminal zinc finger and that the N-terminal domain alone is sufficient to repress, providing the structural logic of GATA engagement.","evidence":"Deletion and site-directed mutagenesis, GST pulldown, reporter assays","pmids":["10801815"],"confidence":"High","gaps":["No crystal/structural model of the FOG2–GATA interface","Did not define the effector domain mechanism of N-terminal repression"]},{"year":2000,"claim":"Demonstrated in vivo requirement in heart morphogenesis, with cardiomyocyte-specific rescue proving myocardial FOG-2 is necessary and sufficient for coronary vessel development and required for septation and looping.","evidence":"Germline knockout and cardiomyocyte transgenic rescue in mice; independent targeted-KO study","pmids":["10892744","10888889"],"confidence":"High","gaps":["Did not identify the transcriptional targets driving coronary angiogenesis","Did not separate GATA-dependent from GATA-independent roles in vivo"]},{"year":2002,"claim":"Placed FOG2 in sex determination, showing the GATA4–FOG2 interaction is required for Sry induction and the male program, establishing a developmental pathway position via two genetic models.","evidence":"Fog2-null and Gata4 interaction-deficient knockin mice with RT-PCR and in situ hybridization","pmids":["12223418"],"confidence":"High","gaps":["Did not identify direct GATA4-FOG2 target genes upstream of Sry","Did not address human relevance at this stage"]},{"year":2002,"claim":"Extended FOG2 repression to additional GATA-driven gonadal promoters and identified retinoid- and lineage-specific modulation, refining the context-dependent nature of its regulatory output.","evidence":"Transfection reporter assays across MIS/inhibin/aromatase/StAR promoters; RXRα ligand-dependent interaction assays","pmids":["12606418","12239108","12480945"],"confidence":"Medium","gaps":["Largely transfection-based without in vivo confirmation of each promoter","Direct chromatin occupancy not demonstrated"]},{"year":2003,"claim":"Showed FOG-2 can switch from repressor to activator depending on cell type, revealing bidirectional modulation of GATA activity at the Kv4.2 locus.","evidence":"Kv4.2 promoter reporter assays with FOG-binding-deficient GATA mutants in cardiac myocytes versus PC12 cells","pmids":["14613857"],"confidence":"Medium","gaps":["GATA-independent activation mechanism in PC12 cells not defined","No in vivo validation"]},{"year":2004,"claim":"Defined a coactivator-competition mechanism, showing FOG-2 competes with GATA-4 for p300 and represses cardiac hypertrophic responses, linking it to stress signaling.","evidence":"Reciprocal co-IP and reporter assays with phenylephrine-induced hypertrophy in cardiomyocytes","pmids":["15220332"],"confidence":"High","gaps":["Relative contribution of p300 competition versus NuRD/CtBP recruitment unresolved","No in vivo hypertrophy model"]},{"year":2005,"claim":"Extended in vivo requirement to diaphragm and lung development and provided the first human loss-of-function evidence, linking FOG2 to pulmonary hypoplasia.","evidence":"ENU splice mutant mouse plus human autopsy case sequencing","pmids":["16103912"],"confidence":"High","gaps":["Did not identify the GATA partner or targets in diaphragm/lung progenitors","Single human case"]},{"year":2009,"claim":"Uncovered a transcription-independent function — direct inhibition of PI3K by binding p85α — establishing FOG2 as a growth suppressor conserved from fly to human.","evidence":"Reciprocal co-IP, cell growth assays, and genetic epistasis in Drosophila and human cells","pmids":["20005803"],"confidence":"High","gaps":["Did not define the FOG2 region binding p85α","Relationship between nuclear and cytoplasmic FOG2 pools unresolved"]},{"year":2009,"claim":"Dissected temporal requirements in heart and identified post-transcriptional control by miR-130a, showing FOG-2 is required in adult myocardium and that microRNA-driven FOG-2 loss phenocopies genetic deficiency.","evidence":"Conditional/inducible Fog2 knockouts; 3′UTR reporter, miR-130a knockdown and transgenic overexpression","pmids":["19411759","19582148","19578715"],"confidence":"High","gaps":["Full angiogenic target set not enumerated","Tnnt1 target shown only at expression level without chromatin analysis"]},{"year":2008,"claim":"Linked FOG-2 to cardiac calcium handling and disease, showing it interacts with TRα1 to suppress SERCA2 and is upregulated in failing hearts with overexpression causing dysfunction.","evidence":"Co-IP, transgenic overexpression, SERCA2 promoter reporter and T3 experiments","pmids":["18658259"],"confidence":"High","gaps":["Direct chromatin occupancy at SERCA2 not shown at this stage","Cause of FOG-2 upregulation in failure undefined"]},{"year":2014,"claim":"Identified NuRD recruitment as the in vivo repression mechanism driving cardiomyocyte proliferation via Cdkn1a/p21, with genetic rescue proving the target relationship.","evidence":"NuRD-binding knock-in mouse (R3K5A), proliferation assays, Cdkn1a reporter, and Fog2(R3K5A);Cdkn1a-/- rescue","pmids":["25196150"],"confidence":"High","gaps":["How NuRD recruitment integrates with CtBP and p300 mechanisms unclear","Other NuRD-dependent targets not mapped"]},{"year":2012,"claim":"Established SUMOylation and additional microRNAs as layers tuning FOG-2 abundance and activity, with SUMOylation attenuating GATA-4 interaction and repression.","evidence":"SUMO-site mutagenesis, SENP de-SUMOylation, reporter assays and co-IP; miR-17-92 3′UTR reporter and rescue","pmids":["23226341","22267003"],"confidence":"High","gaps":["In vivo physiological role of FOG-2 SUMOylation not tested","Upstream signals controlling FOG-2 SUMOylation unknown"]},{"year":2013,"claim":"Connected FOG2 PI3K inhibition to disease physiology, showing TGF-β/miR-200b/c suppression of FOG2 drives Akt/ERK activation and mesangial hypertrophy.","evidence":"siRNA knockdown, miR-200b/c mimic/inhibitor, and pathway western blots in mesangial cells","pmids":["23788640"],"confidence":"High","gaps":["In vivo renal validation not performed","Whether nuclear FOG2 functions contribute not addressed"]},{"year":2014,"claim":"Extended FOG2 partnerships beyond GATA4 to AML1 (in a leukemic fusion) and to the co-repressor Art27 and NKX2.5, broadening its co-regulatory network.","evidence":"Fusion gene characterization with co-IP/reporter assays; yeast two-hybrid validated by co-IP and reporters","pmids":["15705784","24743694"],"confidence":"Medium","gaps":["AML1-FOG2 is a disease-specific fusion, not endogenous FOG2 function","Art27 interaction lacks in vivo validation"]},{"year":2011,"claim":"Refined gonadal roles by conditional ablation, revealing non-overlapping essential functions for FOG2 and GATA4 in testis development with FOG2 loss causing sex reversal.","evidence":"Sf1Cre conditional knockouts with gonadal gene expression and histology","pmids":["21385577"],"confidence":"High","gaps":["Mechanistic basis of FOG2-specific male-pathway block not fully defined"]},{"year":2008,"claim":"Identified GATA4-FOG2 repression of Dkk1 and β-catenin signaling as a node in ovarian versus testis fate, deepening the developmental logic of sex determination.","evidence":"Double-mutant genetic epistasis (Fog2/Dkk1, Gata4ki/Dkk1) and gonadal β-catenin conditional KO","pmids":["18927154"],"confidence":"High","gaps":["Direct chromatin binding of GATA4-FOG2 at Dkk1 not shown"]},{"year":2016,"claim":"Broadened FOG2 function to neocortical neuron differentiation and hepatic metabolism, showing it controls corticothalamic projection neuron identity via Ctip2 and regulates insulin sensitivity and hepatic triglyceride through PPARα.","evidence":"Conditional CThPN knockout with axonal tracing; adenoviral and liver-specific KO models with PPARα rescue","pmids":["27321927","27207553"],"confidence":"High","gaps":["Whether neuronal/hepatic roles depend on GATA partners or PI3K inhibition unresolved","Transcriptional targets in liver beyond PPARα undefined"]},{"year":2024,"claim":"Defined the genomic mechanism of adult atrial rhythm control, showing FOG2 antagonizes a TBX5/GATA4 atrial network at co-bound loci including a SERCA2 enhancer, with genetic epistasis rescuing TBX5-driven arrhythmia.","evidence":"Transgenic overexpression, in vivo/cellular electrophysiology, calcium imaging, ChIP/genomic analysis, and Tbx5+/-;Zfpm2+/- epistasis","pmids":["38189150"],"confidence":"High","gaps":["Full TBX5/GATA4 co-regulated atrial target set not exhaustively defined","Cause of FOG2 upregulation in human heart failure unresolved"]},{"year":null,"claim":"How FOG2 integrates its distinct molecular modes — GATA co-repression via NuRD/CtBP, coactivator competition, SUMO-tuned activity, and cytoplasmic PI3K inhibition — into tissue-specific outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of FOG2 in any complex","Spatial control distinguishing nuclear transcriptional from cytoplasmic PI3K functions not established","Genome-wide direct target catalogs across tissues incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,4,10,11,24,30]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[17,11]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,24,1]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,4]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,4,24,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[2,3,5,12,28]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[17,23]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[24,1]}],"complexes":["NuRD complex"],"partners":["GATA4","CTBP2","P300","TBX5","PIK3R1","THRA","RXRA","NKX2-5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8WW38","full_name":"Zinc finger protein ZFPM2","aliases":["Friend of GATA protein 2","FOG-2","Friend of GATA 2","hFOG-2","Zinc finger protein 89B","Zinc finger protein multitype 2"],"length_aa":1151,"mass_kda":128.2,"function":"Transcription regulator that plays a central role in heart morphogenesis and development of coronary vessels from epicardium, by regulating genes that are essential during cardiogenesis. Essential cofactor that acts via the formation of a heterodimer with transcription factors of the GATA family GATA4, GATA5 and GATA6. Such heterodimer can both activate or repress transcriptional activity, depending on the cell and promoter context. Also required in gonadal differentiation, possibly be regulating expression of SRY. Probably acts a corepressor of NR2F2 (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8WW38/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ZFPM2","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ZFPM2","total_profiled":1310},"omim":[{"mim_id":"619820","title":"ATONAL bHLH TRANSCRIPTION FACTOR 8; ATOH8","url":"https://www.omim.org/entry/619820"},{"mim_id":"616067","title":"46,XY SEX REVERSAL 9; SRXY9","url":"https://www.omim.org/entry/616067"},{"mim_id":"615779","title":"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4","url":"https://www.omim.org/entry/615779"},{"mim_id":"610187","title":"DIAPHRAGMATIC HERNIA 3; DIH3","url":"https://www.omim.org/entry/610187"},{"mim_id":"606215","title":"ATRIOVENTRICULAR SEPTAL DEFECT; AVSD","url":"https://www.omim.org/entry/606215"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":27.5},{"tissue":"ovary","ntpm":32.4}],"url":"https://www.proteinatlas.org/search/ZFPM2"},"hgnc":{"alias_symbol":["PRDM19","FOG2","hFOG-2","ZNF89B"],"prev_symbol":[]},"alphafold":{"accession":"Q8WW38","domains":[{"cath_id":"2.170.270.10","chopping":"100-211","consensus_level":"medium","plddt":78.9295,"start":100,"end":211},{"cath_id":"-","chopping":"342-375","consensus_level":"medium","plddt":79.9394,"start":342,"end":375}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WW38","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WW38-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8WW38-F1-predicted_aligned_error_v6.png","plddt_mean":51.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ZFPM2","jax_strain_url":"https://www.jax.org/strain/search?query=ZFPM2"},"sequence":{"accession":"Q8WW38","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8WW38.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8WW38/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8WW38"}},"corpus_meta":[{"pmid":"3396865","id":"PMC_3396865","title":"fog-2, a germ-line-specific sex determination gene required for hermaphrodite spermatogenesis in Caenorhabditis elegans.","date":"1988","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/3396865","citation_count":318,"is_preprint":false},{"pmid":"10892744","id":"PMC_10892744","title":"FOG-2, a cofactor for GATA transcription factors, is essential for heart morphogenesis and development of coronary vessels from epicardium.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10892744","citation_count":317,"is_preprint":false},{"pmid":"12223418","id":"PMC_12223418","title":"Gonadal differentiation, sex determination and normal Sry expression in mice require direct interaction between transcription partners GATA4 and FOG2.","date":"2002","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12223418","citation_count":274,"is_preprint":false},{"pmid":"20005803","id":"PMC_20005803","title":"Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.","date":"2009","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/20005803","citation_count":258,"is_preprint":false},{"pmid":"9927675","id":"PMC_9927675","title":"Molecular cloning of FOG-2: a modulator of transcription factor GATA-4 in cardiomyocytes.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9927675","citation_count":222,"is_preprint":false},{"pmid":"10330188","id":"PMC_10330188","title":"FOG-2, a heart- and brain-enriched cofactor for GATA transcription factors.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10330188","citation_count":178,"is_preprint":false},{"pmid":"16103912","id":"PMC_16103912","title":"Fog2 is required for normal diaphragm and lung development in mice and humans.","date":"2005","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16103912","citation_count":167,"is_preprint":false},{"pmid":"9927674","id":"PMC_9927674","title":"FOG-2: A novel GATA-family cofactor related to multitype zinc-finger proteins Friend of GATA-1 and U-shaped.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9927674","citation_count":162,"is_preprint":false},{"pmid":"11076749","id":"PMC_11076749","title":"FOG-2, a novel F-box containing protein, associates with the GLD-1 RNA binding protein and directs male sex determination in the C. elegans hermaphrodite germline.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11076749","citation_count":136,"is_preprint":false},{"pmid":"10888889","id":"PMC_10888889","title":"A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2.","date":"2000","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10888889","citation_count":135,"is_preprint":false},{"pmid":"11404479","id":"PMC_11404479","title":"The Friend of GATA proteins U-shaped, FOG-1, and FOG-2 function as negative regulators of blood, heart, and eye development in Drosophila.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11404479","citation_count":130,"is_preprint":false},{"pmid":"10999851","id":"PMC_10999851","title":"Transcription factors GATA-4 and GATA-6 and a GATA family cofactor, FOG-2, are expressed in human ovary and sex cord-derived ovarian tumors.","date":"2000","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10999851","citation_count":103,"is_preprint":false},{"pmid":"15630478","id":"PMC_15630478","title":"fog-2 and the evolution of self-fertile hermaphroditism in Caenorhabditis.","date":"2004","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/15630478","citation_count":102,"is_preprint":false},{"pmid":"10801815","id":"PMC_10801815","title":"A functionally conserved N-terminal domain of the friend of GATA-2 (FOG-2) protein represses GATA4-dependent transcription.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10801815","citation_count":101,"is_preprint":false},{"pmid":"14517948","id":"PMC_14517948","title":"Mutations of ZFPM2/FOG2 gene in sporadic cases of tetralogy of Fallot.","date":"2003","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/14517948","citation_count":97,"is_preprint":false},{"pmid":"10438528","id":"PMC_10438528","title":"hFOG-2, a novel zinc finger protein, binds the co-repressor mCtBP2 and modulates GATA-mediated activation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10438528","citation_count":90,"is_preprint":false},{"pmid":"12606418","id":"PMC_12606418","title":"FOG-2 and GATA-4 Are coexpressed in the mouse ovary and can modulate mullerian-inhibiting substance expression.","date":"2002","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/12606418","citation_count":87,"is_preprint":false},{"pmid":"29985481","id":"PMC_29985481","title":"ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29985481","citation_count":81,"is_preprint":false},{"pmid":"18927154","id":"PMC_18927154","title":"Ovarian development in mice requires the GATA4-FOG2 transcription complex.","date":"2008","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18927154","citation_count":81,"is_preprint":false},{"pmid":"17848526","id":"PMC_17848526","title":"Correct dosage of Fog2 and Gata4 transcription factors is critical for fetal testis development in mice.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17848526","citation_count":78,"is_preprint":false},{"pmid":"23788640","id":"PMC_23788640","title":"FOG2 protein down-regulation by transforming growth factor-β1-induced microRNA-200b/c leads to Akt kinase activation and glomerular mesangial hypertrophy related to diabetic nephropathy.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23788640","citation_count":76,"is_preprint":false},{"pmid":"32795316","id":"PMC_32795316","title":"Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.","date":"2020","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/32795316","citation_count":68,"is_preprint":false},{"pmid":"12213678","id":"PMC_12213678","title":"Developmental expression and spermatogenic stage specificity of transcription factors GATA-1 and GATA-4 and their cofactors FOG-1 and FOG-2 in the mouse testis.","date":"2002","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12213678","citation_count":66,"is_preprint":false},{"pmid":"19411759","id":"PMC_19411759","title":"Fog2 is critical for cardiac function and maintenance of coronary vasculature in the adult mouse heart.","date":"2009","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/19411759","citation_count":65,"is_preprint":false},{"pmid":"20807224","id":"PMC_20807224","title":"New mutations in ZFPM2/FOG2 gene in tetralogy of Fallot and double outlet right ventricle.","date":"2010","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20807224","citation_count":62,"is_preprint":false},{"pmid":"21385577","id":"PMC_21385577","title":"Conditional ablation of Gata4 and Fog2 genes in mice reveals their distinct roles in mammalian sexual differentiation.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21385577","citation_count":61,"is_preprint":false},{"pmid":"24549039","id":"PMC_24549039","title":"Mutations in the FOG2/ZFPM2 gene are associated with anomalies of human testis determination.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24549039","citation_count":59,"is_preprint":false},{"pmid":"12239108","id":"PMC_12239108","title":"Friend of GATA (FOG)-1 and FOG-2 differentially repress the GATA-dependent activity of multiple gonadal promoters.","date":"2002","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/12239108","citation_count":58,"is_preprint":false},{"pmid":"31919993","id":"PMC_31919993","title":"LncRNA ZFPM2-AS1 promotes lung adenocarcinoma progression by interacting with UPF1 to destabilize ZFPM2.","date":"2020","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31919993","citation_count":56,"is_preprint":false},{"pmid":"27321927","id":"PMC_27321927","title":"Corticothalamic Projection Neuron Development beyond Subtype Specification: Fog2 and Intersectional Controls Regulate Intraclass Neuronal Diversity.","date":"2016","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/27321927","citation_count":55,"is_preprint":false},{"pmid":"21919901","id":"PMC_21919901","title":"Novel ZFPM2/FOG2 variants in patients with double outlet right ventricle.","date":"2011","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21919901","citation_count":52,"is_preprint":false},{"pmid":"31297866","id":"PMC_31297866","title":"lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p/VMA21 axis in lung adenocarcinoma.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31297866","citation_count":51,"is_preprint":false},{"pmid":"17568391","id":"PMC_17568391","title":"Candidate genes for congenital diaphragmatic hernia from animal models: sequencing of FOG2 and PDGFRalpha reveals rare variants in diaphragmatic hernia patients.","date":"2007","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/17568391","citation_count":48,"is_preprint":false},{"pmid":"24702427","id":"PMC_24702427","title":"Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia.","date":"2014","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24702427","citation_count":46,"is_preprint":false},{"pmid":"26285119","id":"PMC_26285119","title":"MicroRNA-200c Promotes Suppressive Potential of Myeloid-Derived Suppressor Cells by Modulating PTEN and FOG2 Expression.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26285119","citation_count":45,"is_preprint":false},{"pmid":"8598052","id":"PMC_8598052","title":"FOG1 and FOG2 genes, required for the transcriptional activation of glucose-repressible genes of Kluyveromyces lactis, are homologous to GAL83 and SNF1 of saccharomyces cerevisiae.","date":"1996","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8598052","citation_count":41,"is_preprint":false},{"pmid":"19582148","id":"PMC_19582148","title":"Translational control of FOG-2 expression in cardiomyocytes by microRNA-130a.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19582148","citation_count":41,"is_preprint":false},{"pmid":"32280300","id":"PMC_32280300","title":"YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF4.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32280300","citation_count":40,"is_preprint":false},{"pmid":"12480945","id":"PMC_12480945","title":"Retinoid X receptor alpha represses GATA-4-mediated transcription via a retinoid-dependent interaction with the cardiac-enriched repressor FOG-2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12480945","citation_count":37,"is_preprint":false},{"pmid":"15220332","id":"PMC_15220332","title":"FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15220332","citation_count":36,"is_preprint":false},{"pmid":"14613857","id":"PMC_14613857","title":"GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K(+) channel gene in cardiac myocytes and PC12 cells.","date":"2003","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/14613857","citation_count":35,"is_preprint":false},{"pmid":"34077295","id":"PMC_34077295","title":"SP1-induced lncRNA ZFPM2 antisense RNA 1 (ZFPM2-AS1) aggravates glioma progression via the miR-515-5p/Superoxide dismutase 2 (SOD2) axis.","date":"2021","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34077295","citation_count":31,"is_preprint":false},{"pmid":"18757925","id":"PMC_18757925","title":"Sex change by gene conversion in a Caenorhabditis elegans fog-2 mutant.","date":"2008","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18757925","citation_count":31,"is_preprint":false},{"pmid":"27576955","id":"PMC_27576955","title":"Hypoxia-Induced MicroRNA-429 Promotes Differentiation of MC3T3-E1 Osteoblastic Cells by Mediating ZFPM2 Expression.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27576955","citation_count":30,"is_preprint":false},{"pmid":"11597829","id":"PMC_11597829","title":"Conserved cardiogenic functions of the multitype zinc-finger proteins: U-shaped and FOG-2.","date":"2001","source":"Trends in cardiovascular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/11597829","citation_count":30,"is_preprint":false},{"pmid":"25196150","id":"PMC_25196150","title":"FOG-2 mediated recruitment of the NuRD complex regulates cardiomyocyte proliferation during heart development.","date":"2014","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25196150","citation_count":30,"is_preprint":false},{"pmid":"30365725","id":"PMC_30365725","title":"MicroRNA-221 promotes cell proliferation, migration, and differentiation by regulation of ZFPM2 in osteoblasts.","date":"2018","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/30365725","citation_count":29,"is_preprint":false},{"pmid":"33976749","id":"PMC_33976749","title":"ZFPM2-AS1 transcriptionally mediated by STAT1 regulates thyroid cancer cell growth, migration and invasion via miR-515-5p/TUSC3.","date":"2021","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/33976749","citation_count":29,"is_preprint":false},{"pmid":"15625693","id":"PMC_15625693","title":"Expression of Sox8, Sf1, Gata4, Wt1, Dax1, and Fog2 in the mouse ovarian follicle: implications for the regulation of Amh expression.","date":"2005","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/15625693","citation_count":29,"is_preprint":false},{"pmid":"17309641","id":"PMC_17309641","title":"Disruption of friend of GATA 2 gene (FOG-2) by a de novo t(8;10) chromosomal translocation is associated with heart defects and gonadal dysgenesis.","date":"2007","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17309641","citation_count":29,"is_preprint":false},{"pmid":"18286574","id":"PMC_18286574","title":"Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes.","date":"2008","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18286574","citation_count":28,"is_preprint":false},{"pmid":"31921422","id":"PMC_31921422","title":"LOX family and ZFPM2 as novel diagnostic biomarkers for malignant pleural mesothelioma.","date":"2020","source":"Biomarker research","url":"https://pubmed.ncbi.nlm.nih.gov/31921422","citation_count":27,"is_preprint":false},{"pmid":"26314828","id":"PMC_26314828","title":"MicroRNA-200 promotes lung cancer cell growth through FOG2-independent AKT activation.","date":"2015","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/26314828","citation_count":26,"is_preprint":false},{"pmid":"32561925","id":"PMC_32561925","title":"Long Noncoding RNA ZFPM2-AS1 Knockdown Restrains the Development of Retinoblastoma by Modulating the MicroRNA-515/HOXA1/Wnt/β-Catenin Axis.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32561925","citation_count":25,"is_preprint":false},{"pmid":"32065218","id":"PMC_32065218","title":"ZFPM2-AS1 facilitates cell growth in esophageal squamous cell carcinoma via up-regulating TRAF4.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32065218","citation_count":24,"is_preprint":false},{"pmid":"31692047","id":"PMC_31692047","title":"Long noncoding RNA ZFPM2-AS1 is involved in lung adenocarcinoma via miR-511-3p/AFF4 pathway.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31692047","citation_count":23,"is_preprint":false},{"pmid":"36880413","id":"PMC_36880413","title":"Exosomal ZFPM2-AS1 contributes to tumorigenesis, metastasis, stemness, macrophage polarization, and infiltration in hepatocellular carcinoma through PKM mediated glycolysis.","date":"2023","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/36880413","citation_count":23,"is_preprint":false},{"pmid":"15705784","id":"PMC_15705784","title":"AML1-FOG2 fusion protein in myelodysplasia.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15705784","citation_count":22,"is_preprint":false},{"pmid":"17274974","id":"PMC_17274974","title":"FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17274974","citation_count":22,"is_preprint":false},{"pmid":"28691020","id":"PMC_28691020","title":"miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2/PI3K Pathway.","date":"2017","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/28691020","citation_count":21,"is_preprint":false},{"pmid":"32744687","id":"PMC_32744687","title":"Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32744687","citation_count":21,"is_preprint":false},{"pmid":"31962012","id":"PMC_31962012","title":"Analysis of variants in GATA4 and FOG2/ZFPM2 demonstrates benign contribution to 46,XY disorders of sex development.","date":"2020","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31962012","citation_count":19,"is_preprint":false},{"pmid":"33300060","id":"PMC_33300060","title":"Long non‑coding RNA ZFPM2‑AS1 promotes colorectal cancer progression by sponging miR‑137 to regulate TRIM24.","date":"2020","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/33300060","citation_count":19,"is_preprint":false},{"pmid":"25025186","id":"PMC_25025186","title":"Novel missense variants of ZFPM2/FOG2 identified in conotruncal heart defect patients do not impair interaction with GATA4.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25025186","citation_count":18,"is_preprint":false},{"pmid":"31406464","id":"PMC_31406464","title":"MicroRNA-106b-5p promotes hepatocellular carcinoma development via modulating FOG2.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31406464","citation_count":18,"is_preprint":false},{"pmid":"22267003","id":"PMC_22267003","title":"The miR-17-92 cluster regulates FOG-2 expression and inhibits proliferation of mouse embryonic cardiomyocytes.","date":"2012","source":"Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas","url":"https://pubmed.ncbi.nlm.nih.gov/22267003","citation_count":18,"is_preprint":false},{"pmid":"24743694","id":"PMC_24743694","title":"Art27 interacts with GATA4, FOG2 and NKX2.5 and is a novel co-repressor of cardiac genes.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24743694","citation_count":17,"is_preprint":false},{"pmid":"25484136","id":"PMC_25484136","title":"Novel TNS3-MAP3K3 and ZFPM2-ELF5 fusion genes identified by RNA sequencing in multicystic mesothelioma with t(7;17)(p12;q23) and t(8;11)(q23;p13).","date":"2014","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/25484136","citation_count":17,"is_preprint":false},{"pmid":"19969558","id":"PMC_19969558","title":"Differential developmental expression of transcription factors GATA-4 and GATA-6, their cofactor FOG-2 and downstream target genes in testicular carcinoma in situ and germ cell tumors.","date":"2009","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19969558","citation_count":17,"is_preprint":false},{"pmid":"21947317","id":"PMC_21947317","title":"Association of the ZFPM2 gene with antipsychotic-induced parkinsonism in schizophrenia patients.","date":"2011","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21947317","citation_count":16,"is_preprint":false},{"pmid":"33406278","id":"PMC_33406278","title":"ZFPM2-AS1 facilitates cell proliferation and migration in cutaneous malignant melanoma through modulating miR-650/NOTCH1 signaling.","date":"2021","source":"Dermatologic therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33406278","citation_count":15,"is_preprint":false},{"pmid":"20133352","id":"PMC_20133352","title":"Gene conversion and DNA sequence polymorphism in the sex-determination gene fog-2 and its paralog ftr-1 in Caenorhabditis elegans.","date":"2010","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/20133352","citation_count":15,"is_preprint":false},{"pmid":"31298319","id":"PMC_31298319","title":"Long noncoding RNA ZFPM2-AS1 promotes the tumorigenesis of renal cell cancer via targeting miR-137.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31298319","citation_count":14,"is_preprint":false},{"pmid":"33173620","id":"PMC_33173620","title":"ZFPM2-AS1 promotes the proliferation, migration, and invasion of human non-small cell lung cancer cells involving the JAK-STAT and AKT pathways.","date":"2020","source":"PeerJ","url":"https://pubmed.ncbi.nlm.nih.gov/33173620","citation_count":14,"is_preprint":false},{"pmid":"32326773","id":"PMC_32326773","title":"Downregulation of lncRNA XIST promotes proliferation and differentiation, limits apoptosis of osteoblasts through regulating miR-203-3p/ZFPM2 axis.","date":"2020","source":"Connective tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32326773","citation_count":14,"is_preprint":false},{"pmid":"24769157","id":"PMC_24769157","title":"Exome sequencing identifies ZFPM2 as a cause of familial isolated congenital diaphragmatic hernia and possibly cardiovascular malformations.","date":"2014","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24769157","citation_count":14,"is_preprint":false},{"pmid":"34102651","id":"PMC_34102651","title":"Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis.","date":"2021","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/34102651","citation_count":13,"is_preprint":false},{"pmid":"18658259","id":"PMC_18658259","title":"Increased FOG-2 in failing myocardium disrupts thyroid hormone-dependent SERCA2 gene transcription.","date":"2008","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/18658259","citation_count":13,"is_preprint":false},{"pmid":"32382322","id":"PMC_32382322","title":"Bioinformatics analyses and biological function of lncRNA ZFPM2-AS1 and ZFPM2 gene in hepatocellular carcinoma.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/32382322","citation_count":12,"is_preprint":false},{"pmid":"26959486","id":"PMC_26959486","title":"CpG island shore methylation of ZFPM2 is identified in tetralogy of fallot samples.","date":"2016","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/26959486","citation_count":12,"is_preprint":false},{"pmid":"33202802","id":"PMC_33202802","title":"Variants of STAR, AMH and ZFPM2/FOG2 May Contribute towards the Broad Phenotype Observed in 46,XY DSD Patients with Heterozygous Variants of NR5A1.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33202802","citation_count":12,"is_preprint":false},{"pmid":"19645582","id":"PMC_19645582","title":"Association of HOXA10, ZFPM2, and MMP2 genes with scrotal hernias evaluated via biological candidate gene analyses in pigs.","date":"2009","source":"American journal of veterinary research","url":"https://pubmed.ncbi.nlm.nih.gov/19645582","citation_count":12,"is_preprint":false},{"pmid":"38189150","id":"PMC_38189150","title":"A Genomic Link From Heart Failure to Atrial Fibrillation Risk: FOG2 Modulates a TBX5/GATA4-Dependent Atrial Gene Regulatory Network.","date":"2024","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/38189150","citation_count":11,"is_preprint":false},{"pmid":"33215431","id":"PMC_33215431","title":"LncRNA ZFPM2-AS1 aggravates the malignant development of breast cancer via upregulating JMJD6.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33215431","citation_count":11,"is_preprint":false},{"pmid":"27207553","id":"PMC_27207553","title":"A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27207553","citation_count":11,"is_preprint":false},{"pmid":"24469719","id":"PMC_24469719","title":"Identification of novel significant variants of ZFPM2/FOG2 in non-syndromic Tetralogy of Fallot and double outlet right ventricle in a Chinese Han population.","date":"2014","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/24469719","citation_count":10,"is_preprint":false},{"pmid":"34989314","id":"PMC_34989314","title":"lncRNA ZFPM2-AS1 promotes retinoblastoma progression by targeting microRNA miR-511-3p/paired box protein 6 (PAX6) axis.","date":"2022","source":"Bioengineered","url":"https://pubmed.ncbi.nlm.nih.gov/34989314","citation_count":10,"is_preprint":false},{"pmid":"15643620","id":"PMC_15643620","title":"ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia.","date":"2005","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/15643620","citation_count":10,"is_preprint":false},{"pmid":"35578882","id":"PMC_35578882","title":"ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple Cancer Types.","date":"2023","source":"Mini reviews in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35578882","citation_count":9,"is_preprint":false},{"pmid":"23226341","id":"PMC_23226341","title":"SUMOylation regulates the transcriptional repression activity of FOG-2 and its association with GATA-4.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23226341","citation_count":9,"is_preprint":false},{"pmid":"19578715","id":"PMC_19578715","title":"Cardiac expression of Tnnt1 requires the GATA4-FOG2 transcription complex.","date":"2009","source":"TheScientificWorldJournal","url":"https://pubmed.ncbi.nlm.nih.gov/19578715","citation_count":8,"is_preprint":false},{"pmid":"29018978","id":"PMC_29018978","title":"Identification of ZFPM2 mutations in sporadic conotruncal heart defect patients.","date":"2017","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/29018978","citation_count":8,"is_preprint":false},{"pmid":"23029311","id":"PMC_23029311","title":"GATA-4 and FOG-2 expression in pediatric ovarian sex cord-stromal tumors replicates embryonal gonadal phenotype: results from the TREP project.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23029311","citation_count":8,"is_preprint":false},{"pmid":"30108331","id":"PMC_30108331","title":"Correction: ZFPM2-AS1, a novel lncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/30108331","citation_count":8,"is_preprint":false},{"pmid":"35098483","id":"PMC_35098483","title":"Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.","date":"2022","source":"Molecular biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35098483","citation_count":7,"is_preprint":false},{"pmid":"32158261","id":"PMC_32158261","title":"Long Noncoding RNA ZFPM2-AS1 Enhances the Malignancy of Cervical Cancer by Functioning as a Molecular Sponge of microRNA-511-3p and Consequently Increasing FGFR2 Expression.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32158261","citation_count":7,"is_preprint":false},{"pmid":"36524359","id":"PMC_36524359","title":"Genome stability‑related lncRNA ZFPM2‑AS1 promotes tumor progression via miR‑3065‑5p/XRCC4 in hepatocellular carcinoma.","date":"2022","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36524359","citation_count":7,"is_preprint":false},{"pmid":"35119225","id":"PMC_35119225","title":"Comprehensive variant calling from whole-genome sequencing identifies a complex inversion that disrupts ZFPM2 in familial congenital diaphragmatic hernia.","date":"2022","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35119225","citation_count":7,"is_preprint":false},{"pmid":"35276693","id":"PMC_35276693","title":"LncRNA ZFPM2-AS1 drives the progression of nasopharyngeal carcinoma via modulating the downstream miR-3612/DTL signaling.","date":"2022","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/35276693","citation_count":6,"is_preprint":false},{"pmid":"26207917","id":"PMC_26207917","title":"Glioma Association and Balancing Selection of ZFPM2.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26207917","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51913,"output_tokens":8315,"usd":0.140232,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17964,"output_tokens":6019,"usd":0.120148,"stage2_stop_reason":"end_turn"},"total_usd":0.26038,"stage1_batch_id":"msgbatch_01UT1AahFPCAyn2uVweS7A9z","stage2_batch_id":"msgbatch_01HuKWtKNT4Pqj1bc8eEP5RV","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"FOG-2 (ZFPM2) is a nuclear protein containing eight zinc finger motifs that physically associates with the N-terminal zinc finger of GATA-4 both in vitro and in vivo, and overexpression of FOG-2 represses GATA-4-dependent transcription from multiple cardiac-restricted promoters in NIH 3T3 cells and primary rat cardiomyocytes.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, co-transfection reporter assays in cardiomyocytes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro binding and in vivo co-IP replicated independently in three simultaneous papers (PMID:9927675, PMID:10330188, PMID:9927674) using multiple orthogonal methods\",\n      \"pmids\": [\"9927675\", \"10330188\", \"9927674\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"FOG-2 interacts with the co-repressor C-terminal binding protein-2 (CtBP2) via a conserved PIDLS motif, and this interaction is required for repression activity in some contexts (repression of crystal cell production in Drosophila) but is NOT required for FOG-2-mediated repression of GATA4-dependent transcription in mammalian cells.\",\n      \"method\": \"GST pulldown, co-transfection luciferase reporter assays, site-directed mutagenesis of PIDLS motif\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis of interaction motif combined with functional reporter assays, replicated in PMID:11404479\",\n      \"pmids\": [\"10438528\", \"10801815\", \"11404479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FOG-2 knockout mice die at midgestation with thin ventricular myocardium, common atrioventricular canal, tetralogy of Fallot malformation, and complete absence of coronary vasculature despite an intact epicardial layer. Transgenic re-expression of FOG-2 specifically in cardiomyocytes rescues the coronary vascular phenotype, demonstrating that FOG-2 function in myocardium is required and sufficient for coronary vessel development.\",\n      \"method\": \"Germline knockout mouse, transgenic rescue with cardiomyocyte-specific re-expression, histology, ICAM-2/FLK-1 marker analysis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — germline KO with defined phenotype plus transgenic rescue experiment in a single rigorous study\",\n      \"pmids\": [\"10892744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"FOG-2 (Zfpm2) deficiency in mice produces a syndrome of tricuspid atresia including absent tricuspid valve, large atrial septal defect, ventricular septal defect, elongated left ventricular outflow tract, and hypoplasia of the compact zone of the left ventricle, establishing Zfpm2 as required for normal cardiac looping and septation.\",\n      \"method\": \"Targeted mutagenesis (gene knockout), histological and morphological analysis of embryos\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — targeted KO with defined cardiac phenotype, independently confirmed in PMID:10892744\",\n      \"pmids\": [\"10888889\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A conserved N-terminal domain of FOG-2 (amino acids 1–247) is both necessary and sufficient to repress GATA4-dependent transcription, independent of CtBP2 interaction. Zinc fingers 1 and 6 of FOG-2 each interact with evolutionarily conserved motifs in the N-terminal zinc finger of GATA proteins. A nuclear localization signal (RKRRK, aa 736–740) is required for nuclear targeting of FOG-2.\",\n      \"method\": \"Deletion mutagenesis, co-transfection reporter assays, GST pulldown with GATA protein fragments, site-directed mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstitution-style domain mapping with mutagenesis, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"10801815\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GATA4 and FOG2 physical interaction is required for normal gonadal differentiation and Sry expression. XY mice homozygous for Fog2 null or a Gata4 knockin that abrogates FOG co-factor binding show severely reduced Sry transcript levels at E11.5, loss of Sox9/Mis/Dhh expression, and ectopic Wnt4 expression, while Wt1 and Sf1 are unaffected.\",\n      \"method\": \"Genetic epistasis using Fog2-null and Gata4(ki/ki) mouse models, quantitative RT-PCR, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genetic models with orthogonal molecular readouts establish pathway position\",\n      \"pmids\": [\"12223418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"FOG-2 represses crystal cell production in Drosophila, but a FOG-2 mutant lacking the conserved CtBP-binding motif (PIDLS) fails to repress crystal cell lineage, indicating that CtBP recruitment is required for FOG-2 function in blood but not in cardiac or eye contexts, revealing context-dependent repression mechanisms.\",\n      \"method\": \"Transgenic Drosophila overexpression, CtBP-binding mutant analysis, cell lineage counting\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined phenotypic readout with mutagenesis in a model organism, single lab\",\n      \"pmids\": [\"11404479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FOG-2 represses GATA-4-mediated transactivation of the Müllerian-inhibiting substance (MIS) gene in granulosa cells, and its loss of expression in fetal Sertoli cells accompanies testicular cord formation, suggesting a role in suppressing MIS in the developing ovary.\",\n      \"method\": \"In vitro transfection reporter assays in granulosa cells, Northern blot, RNA in situ hybridization, immunohistochemistry\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — transfection assay plus expression analysis, single lab, two orthogonal approaches\",\n      \"pmids\": [\"12606418\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"FOG-1 and FOG-2 differentially repress GATA-dependent promoter activities of multiple gonadal genes (MIS, inhibin alpha, P450 aromatase, StAR) in testicular cells in a promoter- and cell-type-dependent manner.\",\n      \"method\": \"Co-transfection luciferase reporter assays in testicular cell lines\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — transfection assays across multiple promoters, single lab\",\n      \"pmids\": [\"12239108\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Liganded RXRα interacts directly with GATA-4 (via its DNA-binding domain to the second zinc finger of GATA-4) and with FOG-2 in a 9-cis-RA-dependent manner. Co-expression of liganded RXRα and FOG-2 results in additive repression of GATA-4 activity in ventricular myocytes, revealing a retinoid-dependent mechanism linking RXRα to the FOG-2 co-repressor complex.\",\n      \"method\": \"GST pulldown, co-transfection reporter assays in cardiomyocytes, ligand-dependent interaction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — GST pulldown plus functional reporter assay, single lab, two orthogonal methods\",\n      \"pmids\": [\"12480945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"FOG-2 regulates Kv4.2 potassium channel gene transcription by differentially modulating GATA-dependent activation: in cardiac myocytes FOG-2 suppresses GATA-induced transcription through a GATA-FOG complex, whereas in PC12 cells FOG-2 enhances GATA activity through a GATA-independent mechanism.\",\n      \"method\": \"Transient transfection with Kv4.2 promoter-luciferase reporters, use of GATA mutants unable to bind FOG, in cardiac myocytes and PC12 cells\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reporter assays with GATA interaction-deficient mutants establishing mechanism, single lab\",\n      \"pmids\": [\"14613857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"FOG-2 physically interacts with the transcriptional coactivator p300, competes with GATA-4 for p300 binding, reduces the GATA-4/p300 interaction, and represses phenylephrine-induced hypertrophic responses (myofibrillar organization, cell size increase, hypertrophy-associated gene transcription) in cardiac myocytes. In COS7 cells with disrupted endogenous p300, FOG-2 cannot repress baseline GATA-4 activity but can repress p300-mediated GATA-4 enhancement.\",\n      \"method\": \"Co-immunoprecipitation/western blot, co-transfection reporter assays, phenylephrine-induced hypertrophy model in cardiomyocytes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP plus functional cellular phenotype with mechanistic dissection, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"15220332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Fog2 (Zfpm2) is required for normal diaphragm and lung development; an ENU-induced splice donor mutation in mice produces pulmonary hypoplasia and abnormal diaphragmatic development, and a de novo FOG2 premature stop codon was identified in a human infant with severe bilateral pulmonary hypoplasia and abnormally muscularized diaphragm.\",\n      \"method\": \"ENU mutagenesis screen in mice, DNA sequencing of splice site and coding sequence, human autopsy case sequencing\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function in mouse model with defined phenotype corroborated by human genetic evidence\",\n      \"pmids\": [\"16103912\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FOG-2 attenuates endothelial-to-mesenchymal transformation (EMT) in developing endocardial cushions; FOG-2-deficient mice show a 78% increase in outflow tract cushion EMT and 35% increase in atrioventricular cushion EMT in collagen gel invasion assays, without differences in mesenchymal cell proliferation, differentiation, apoptosis, or myocardialization.\",\n      \"method\": \"FOG-2 knockout mouse model, collagen gel invasion assay for EMT, proliferation/apoptosis/differentiation assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO mouse with specific in vitro functional assay and multiple negative controls ruling out alternative mechanisms\",\n      \"pmids\": [\"17274974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Loss of the FOG-2–GATA4 interaction (via Gata4(ki/ki) or Fog2(-/-)) results in the absence of ovarian development and identifies Dkk1 (a secreted inhibitor of canonical β-catenin signaling) as a target of GATA4-FOG2 repression. Ablation of β-catenin in gonads disrupts female development, and double mutants Gata4(ki/ki);Dkk1(-/-) or Fog2(-/-);Dkk1(-/-) show partial restoration of normal ovarian gene expression.\",\n      \"method\": \"Genetic epistasis with double mutants (Fog2/Dkk1 and Gata4(ki)/Dkk1), gonad-specific β-catenin conditional knockout, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-mutant genetic epistasis with multiple lines converging on same pathway, rigorous controls\",\n      \"pmids\": [\"18927154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"FOG-2 physically interacts with thyroid hormone receptor-alpha1 (TRα1) and abrogates T3-mediated SERCA2 gene promoter activation. FOG-2 is upregulated in human and murine failing hearts; cardiac-specific FOG-2 overexpression in transgenic mice causes depressed cardiac function, activation of the fetal gene program, and reduced SERCA2 transcript and protein levels.\",\n      \"method\": \"Co-immunoprecipitation, transgenic mouse overexpression, SERCA2 promoter-reporter assays, T3-treatment experiments in cardiomyocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP establishes physical interaction; transgenic model with functional phenotype; promoter assay defines mechanism; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"18658259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FOG-2 expression in cardiomyocytes is post-transcriptionally regulated by microRNA-130a, which binds a conserved site in the FOG-2 3′ UTR. Cardiomyocyte-specific transgenic overexpression of miR-130a reduces FOG-2 protein by up to 80% and causes ventricular wall hypoplasia and ventricular septal defects resembling FOG-2 deficiency.\",\n      \"method\": \"Luciferase 3′ UTR reporter assay, miR-130a knockdown in fibroblasts, transgenic mouse overexpression of miR-130a, western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3′ UTR reporter with site mutagenesis, knockdown validation, and in vivo transgenic phenotype; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19582148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"FOG-2 and its target USH (Drosophila) inhibit PI3K activity by directly binding to p85α, the regulatory subunit of PI3K, interfering with PI3K complex formation, thereby suppressing cell growth. This mechanism is conserved: human FOG2 also binds p85α and suppresses PI3K-dependent growth.\",\n      \"method\": \"Co-immunoprecipitation of FOG2 with p85α, cell growth assays, genetic epistasis in Drosophila fat body and human cells\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP demonstrating direct protein-protein interaction, functional epistasis in two organisms, rigorous controls\",\n      \"pmids\": [\"20005803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Early cardiomyocyte-restricted loss of Fog2 recapitulates cardiac and coronary defects of germline knockouts. Later cardiomyocyte-restricted Fog2 loss (Fog2MC) causes severely depressed ventricular function and death at 8–14 weeks with paucity of coronary vessels, myocardial hypoxia, cardiomyocyte apoptosis, and cardiac fibrosis. Ablation of the FOG2–GATA4 interaction produces similar adult phenotypes, and loss of FOG2 or FOG2–GATA4 interaction alters expression of angiogenesis-related genes.\",\n      \"method\": \"Spatiotemporally regulated conditional Fog2 knockout (Cre-lox), inducible adult-specific Fog2 deletion, Gata4 interaction-domain mutation, echocardiography, histology, gene expression\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple conditional models with defined temporal and spatial specificity, replicated across embryonic and adult contexts in same study\",\n      \"pmids\": [\"19411759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cardiac expression of slow skeletal troponin T (Tnnt1) strictly depends on physical interaction between GATA4 and FOG2 in the myocardium of both atria and ventricles, identifying Tnnt1 as a direct transcriptional target of the GATA4-FOG2 complex.\",\n      \"method\": \"Genetic analysis using Gata4(ki/ki) and Fog2(-/-) mouse models, gene expression analysis\",\n      \"journal\": \"TheScientificWorldJournal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — genetic epistasis in two mouse models, single lab, limited to expression readout without direct chromatin analysis\",\n      \"pmids\": [\"19578715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Conditional somatic ablation of Fog2 in gonadal cells causes an early partial block in the male pathway and sex reversal, while GATA4 loss primarily disrupts Dmrt1 expression and testis cord morphogenesis. These experiments reveal non-overlapping essential functions for GATA4 and FOG2 in testis development.\",\n      \"method\": \"Sf1Cre-mediated conditional knockout of Gata4 and Fog2, gonadal gene expression analysis, histology\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined cellular compartment and multiple molecular readouts, single lab but orthogonal histological and expression methods\",\n      \"pmids\": [\"21385577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The miR-17-5p and miR-20a members of the miR-17-92 cluster directly target sites in the FOG-2 3′ UTR and post-transcriptionally repress FOG-2 expression. Overexpression of miR-17-92 inhibits embryonic cardiomyocyte proliferation, an effect rescued by FOG-2 re-expression.\",\n      \"method\": \"Luciferase 3′ UTR reporter assay, RT-PCR, western blot, EdU proliferation assay with FOG-2 rescue in embryonic cardiomyocytes\",\n      \"journal\": \"Brazilian journal of medical and biological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3′ UTR reporter plus rescue experiment, single lab, two orthogonal methods\",\n      \"pmids\": [\"22267003\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"FOG-2 is SUMOylated at four lysine residues (K324, K471, K915, K955). Mutation of SUMOylation sites or de-SUMOylation with SENP-1/SENP-8 results in stronger transcriptional repression activity. Increased SUMOylation (SUMO-1 overexpression or SUMO-1–FOG-2 fusion) abolishes repression of GATA-4-mediated BNP promoter activation. GATA-4 co-expression enhances FOG-2 SUMOylation, and a SUMO-deficient FOG-2 mutant shows increased interaction with GATA-4.\",\n      \"method\": \"Site-directed mutagenesis of SUMOylation sites, SENP-mediated de-SUMOylation, SUMO-1 overexpression, reporter assays, co-immunoprecipitation\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of PTM sites with functional reporter readout and co-IP, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"23226341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TGF-β1 activates Akt in glomerular mesangial cells by inducing miR-200b/c, which targets FOG2 (an inhibitor of PI3K activation). FOG2 knockdown by siRNA activates both Akt and ERK through PI3K activation and increases protein content/cell ratio, mimicking hypertrophy. miR-200b/c inhibitors attenuate TGF-β-induced FOG2 decrease and mesangial hypertrophy.\",\n      \"method\": \"siRNA knockdown of FOG2, miR-200b/c mimic/inhibitor transfection, western blot for PI3K-Akt-ERK pathway, protein content assay in mesangial cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA loss-of-function with defined PI3K pathway phenotype plus miRNA mimic/inhibitor rescue, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"23788640\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOG-2 recruits the NuRD (Nucleosome Remodeling and Deacetylase) complex and this interaction is required in vivo for cardiomyocyte proliferation. Mice carrying an R3K5A mutation that disrupts NuRD binding show perinatal lethality, ventricular and atrial septal defects, thin ventricular myocardium, and 31% reduction in cardiomyocyte proliferation. The cell cycle inhibitor Cdkn1a (p21) is upregulated 2-fold, and genetic ablation of Cdkn1a partially rescues left ventricular wall thickness in FOG-2(R3K5A) mice.\",\n      \"method\": \"Knock-in mouse with NuRD-binding mutation (R3K5A), cardiomyocyte proliferation measurement, Cdkn1a promoter-reporter assay, double mutant rescue (Fog2(R3K5A);Cdkn1a-/-)\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knock-in mutagenesis of interaction motif, defined cellular phenotype, promoter assay, and genetic rescue experiment in single study\",\n      \"pmids\": [\"25196150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"FOG-2 interacts with AML1 in the AML1-FOG2 fusion protein found in myelodysplasia with t(X;21). AML1-FOG2 represses transcriptional activity of both CBF and GATA1. AML1-FOG2 retains the CtBP-recruiting motif and associates with CtBP in a protein complex, implicating CtBP in AML1-FOG2-mediated transcriptional repression.\",\n      \"method\": \"Characterization of t(X;21) fusion gene, co-immunoprecipitation of AML1-FOG2 with CtBP, transcriptional reporter assays for CBF and GATA1 activity\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and reporter assays in a disease context, single lab, two orthogonal methods\",\n      \"pmids\": [\"15705784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Art27 interacts physically with FOG-2, GATA-4, and NKX2.5 (identified by yeast two-hybrid and validated by co-immunoprecipitation) and functions as a co-repressor that down-regulates GATA-4/FOG-2 activity on cardiac-specific promoters (αMHC, ANP, BNP) in cardiomyocytes.\",\n      \"method\": \"Yeast two-hybrid library screen, co-immunoprecipitation, co-transfection luciferase reporter assays, microarray gene expression in cardiomyocytes\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — yeast two-hybrid confirmed by co-IP plus functional reporter assays, single lab\",\n      \"pmids\": [\"24743694\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Two FOG2 missense mutations (p.S402R and p.R260Q/p.M544I) identified by whole exome sequencing in patients with 46,XY gonadal dysgenesis impair the ability of FOG2 protein to interact with GATA4, as demonstrated by functional interaction assays, providing the first evidence linking FOG2 coding mutations to 46,XY DSD in humans.\",\n      \"method\": \"Whole exome sequencing, protein-protein interaction functional assays (GST pulldown or equivalent), clinical genetics\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay of protein-protein interaction for patient variants, single lab\",\n      \"pmids\": [\"24549039\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FOG-2 (Fog2) controls corticothalamic projection neuron (CThPN) molecular differentiation, axonal targeting, and subtype diversity in the neocortex. Loss of Fog2 specifically disrupts differentiation of CThPN subsets specialized in motor function, in part by regulating the expression level of Ctip2 via combinatorial interactions with other molecular controls.\",\n      \"method\": \"Conditional knockout of Fog2 in CThPN, in situ hybridization, immunohistochemistry, axonal tracing, gene expression analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO with defined neuronal phenotype and molecular target identification, single lab\",\n      \"pmids\": [\"27321927\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hepatic FOG2 regulates insulin sensitivity and hepatic triglyceride accumulation through PPARα. FOG2 overexpression attenuates insulin signaling in hepatocytes; FOG2 knockdown ameliorates insulin resistance in db/db mice. FOG2 overexpression reduces hepatic TG accumulation via increased PPARα expression; re-expression of PPARα reverses the effects of FOG2 knockdown on insulin sensitivity and hepatic TG. FOG2 liver-specific knockout mice exhibit enhanced insulin sensitivity and elevated hepatic TG, both reversed by Ad-PPARα.\",\n      \"method\": \"Adenoviral FOG2 overexpression and shRNA knockdown in vivo and in vitro, liver-specific conditional knockout mouse, insulin tolerance tests, hepatic TG measurement, PPARα rescue experiments\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO plus adenoviral gain/loss-of-function in multiple mouse models, PPARα rescue establishes epistatic pathway placement\",\n      \"pmids\": [\"27207553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"FOG2 is significantly upregulated in human atria during heart failure. Cardiomyocyte-specific FOG2 overexpression in mice causes primary spontaneous atrial fibrillation (before structural remodeling) by generating arrhythmia substrate including calcium cycling defects. FOG2 represses TBX5-dependent atrial gene expression by binding a subset of GATA4 and TBX5 co-bound genomic locations, including a conserved enhancer at the Atp2a2 (SERCA2) locus. Atrial rhythm abnormalities from Tbx5 haploinsufficiency are rescued by Zfpm2 haploinsufficiency, establishing FOG2 as antagonizing TBX5 in an atrial gene regulatory network.\",\n      \"method\": \"Cardiac-specific FOG2 transgenic overexpression, in vivo electrophysiology, cellular electrophysiology, calcium imaging, ChIP/genomic analysis of enhancer activity, genetic epistasis (Tbx5+/-;Zfpm2+/- double mutants), gene expression analysis\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — transgenic mouse model with whole-animal electrophysiology, multiple cellular phenotypes, genomic mechanism, and genetic epistasis rescue in a single study\",\n      \"pmids\": [\"38189150\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ZFPM2/FOG-2 is a multi-zinc-finger transcriptional co-regulator that physically associates (via zinc fingers 1 and 6) with the N-terminal zinc finger of GATA4/GATA1 to modulate GATA-dependent transcription in a context-dependent manner (repression or activation), recruits co-repressor complexes including NuRD and CtBP, is itself regulated by SUMOylation (which attenuates its repressive activity) and by multiple microRNAs (miR-130a, miR-200b/c, miR-17-92) targeting its 3′ UTR, directly inhibits PI3K activity by binding p85α, interacts with thyroid hormone receptor-α1 to suppress SERCA2 expression, and is required in cardiomyocytes for heart morphogenesis, coronary angiogenesis, adult cardiac rhythm (by antagonizing a TBX5/GATA4 atrial gene regulatory network), and cardiomyocyte proliferation (through NuRD-mediated repression of Cdkn1a/p21), as well as in gonadal somatic cells for Sry induction and male sex determination, and in diaphragm/lung progenitors for normal diaphragm and pulmonary development.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ZFPM2/FOG-2 is a multi-zinc-finger nuclear transcriptional co-regulator that controls organ development and adult tissue homeostasis primarily by binding GATA transcription factors and modulating their activity in a promoter- and cell-type-dependent manner [#0, #4, #10]. It associates through zinc fingers 1 and 6 with conserved motifs in the N-terminal zinc finger of GATA-4, with an N-terminal domain (aa 1–247) both necessary and sufficient for repression and a defined nuclear localization signal directing nuclear targeting [#4]. FOG-2 represses GATA-dependent transcription by recruiting co-repressor machinery — CtBP via a conserved PIDLS motif (required in some lineages but dispensable for cardiac GATA4 repression) and the NuRD nucleosome remodeling/deacetylase complex, the latter being required in cardiomyocytes for proliferation through repression of the cell-cycle inhibitor Cdkn1a/p21 [#1, #24]; it can also antagonize GATA4 coactivation by competing with p300 [#11]. Its repressive output is tuned by SUMOylation, which attenuates GATA-4 interaction and repression, and its abundance is set post-transcriptionally by 3′UTR-targeting microRNAs including miR-130a and the miR-17-92 cluster [#22, #16, #21]. In the heart, FOG-2 function in myocardium is required for ventricular development, cardiac septation/looping, and coronary vessel formation, and in the adult it antagonizes a TBX5/GATA4 atrial gene regulatory network — including at a SERCA2/Atp2a2 enhancer — to maintain normal atrial rhythm [#2, #3, #18, #30]. In gonadal somatic cells the GATA4–FOG2 interaction is required for Sry induction and male sex determination, with human FOG2 coding mutations that disrupt GATA4 binding causing 46,XY gonadal dysgenesis, and FOG-2 is also required for normal diaphragm and lung development, with a human loss-of-function allele linked to pulmonary hypoplasia [#5, #27, #12]. Beyond transcription, FOG-2 directly inhibits PI3K by binding the p85α regulatory subunit, a conserved mechanism that restrains cell growth and influences hepatic insulin sensitivity via PPARα [#17, #23, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Established the founding molecular activity — that ZFPM2 is a nuclear zinc-finger protein that physically engages GATA-4 and represses GATA-dependent cardiac transcription, defining it as a GATA co-regulator.\",\n      \"evidence\": \"Co-IP, GST pulldown and reporter assays in cardiomyocytes, replicated across three simultaneous papers\",\n      \"pmids\": [\"9927675\", \"10330188\", \"9927674\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve which zinc fingers mediate binding\", \"Did not identify the co-repressor machinery responsible for repression\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified a CtBP co-repressor recruitment mechanism via the PIDLS motif and showed it is context-dependent, distinguishing lineage-specific from cardiac repression modes.\",\n      \"evidence\": \"GST pulldown, reporter assays and PIDLS motif mutagenesis\",\n      \"pmids\": [\"10438528\", \"10801815\", \"11404479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not explain what co-repressor substitutes for CtBP in cardiac GATA4 repression\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapped the interaction and repression determinants, showing zinc fingers 1 and 6 bind the GATA N-terminal zinc finger and that the N-terminal domain alone is sufficient to repress, providing the structural logic of GATA engagement.\",\n      \"evidence\": \"Deletion and site-directed mutagenesis, GST pulldown, reporter assays\",\n      \"pmids\": [\"10801815\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal/structural model of the FOG2–GATA interface\", \"Did not define the effector domain mechanism of N-terminal repression\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated in vivo requirement in heart morphogenesis, with cardiomyocyte-specific rescue proving myocardial FOG-2 is necessary and sufficient for coronary vessel development and required for septation and looping.\",\n      \"evidence\": \"Germline knockout and cardiomyocyte transgenic rescue in mice; independent targeted-KO study\",\n      \"pmids\": [\"10892744\", \"10888889\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the transcriptional targets driving coronary angiogenesis\", \"Did not separate GATA-dependent from GATA-independent roles in vivo\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed FOG2 in sex determination, showing the GATA4–FOG2 interaction is required for Sry induction and the male program, establishing a developmental pathway position via two genetic models.\",\n      \"evidence\": \"Fog2-null and Gata4 interaction-deficient knockin mice with RT-PCR and in situ hybridization\",\n      \"pmids\": [\"12223418\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify direct GATA4-FOG2 target genes upstream of Sry\", \"Did not address human relevance at this stage\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Extended FOG2 repression to additional GATA-driven gonadal promoters and identified retinoid- and lineage-specific modulation, refining the context-dependent nature of its regulatory output.\",\n      \"evidence\": \"Transfection reporter assays across MIS/inhibin/aromatase/StAR promoters; RXRα ligand-dependent interaction assays\",\n      \"pmids\": [\"12606418\", \"12239108\", \"12480945\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Largely transfection-based without in vivo confirmation of each promoter\", \"Direct chromatin occupancy not demonstrated\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showed FOG-2 can switch from repressor to activator depending on cell type, revealing bidirectional modulation of GATA activity at the Kv4.2 locus.\",\n      \"evidence\": \"Kv4.2 promoter reporter assays with FOG-binding-deficient GATA mutants in cardiac myocytes versus PC12 cells\",\n      \"pmids\": [\"14613857\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"GATA-independent activation mechanism in PC12 cells not defined\", \"No in vivo validation\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined a coactivator-competition mechanism, showing FOG-2 competes with GATA-4 for p300 and represses cardiac hypertrophic responses, linking it to stress signaling.\",\n      \"evidence\": \"Reciprocal co-IP and reporter assays with phenylephrine-induced hypertrophy in cardiomyocytes\",\n      \"pmids\": [\"15220332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of p300 competition versus NuRD/CtBP recruitment unresolved\", \"No in vivo hypertrophy model\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Extended in vivo requirement to diaphragm and lung development and provided the first human loss-of-function evidence, linking FOG2 to pulmonary hypoplasia.\",\n      \"evidence\": \"ENU splice mutant mouse plus human autopsy case sequencing\",\n      \"pmids\": [\"16103912\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the GATA partner or targets in diaphragm/lung progenitors\", \"Single human case\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Uncovered a transcription-independent function — direct inhibition of PI3K by binding p85α — establishing FOG2 as a growth suppressor conserved from fly to human.\",\n      \"evidence\": \"Reciprocal co-IP, cell growth assays, and genetic epistasis in Drosophila and human cells\",\n      \"pmids\": [\"20005803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the FOG2 region binding p85α\", \"Relationship between nuclear and cytoplasmic FOG2 pools unresolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dissected temporal requirements in heart and identified post-transcriptional control by miR-130a, showing FOG-2 is required in adult myocardium and that microRNA-driven FOG-2 loss phenocopies genetic deficiency.\",\n      \"evidence\": \"Conditional/inducible Fog2 knockouts; 3′UTR reporter, miR-130a knockdown and transgenic overexpression\",\n      \"pmids\": [\"19411759\", \"19582148\", \"19578715\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full angiogenic target set not enumerated\", \"Tnnt1 target shown only at expression level without chromatin analysis\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Linked FOG-2 to cardiac calcium handling and disease, showing it interacts with TRα1 to suppress SERCA2 and is upregulated in failing hearts with overexpression causing dysfunction.\",\n      \"evidence\": \"Co-IP, transgenic overexpression, SERCA2 promoter reporter and T3 experiments\",\n      \"pmids\": [\"18658259\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin occupancy at SERCA2 not shown at this stage\", \"Cause of FOG-2 upregulation in failure undefined\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified NuRD recruitment as the in vivo repression mechanism driving cardiomyocyte proliferation via Cdkn1a/p21, with genetic rescue proving the target relationship.\",\n      \"evidence\": \"NuRD-binding knock-in mouse (R3K5A), proliferation assays, Cdkn1a reporter, and Fog2(R3K5A);Cdkn1a-/- rescue\",\n      \"pmids\": [\"25196150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NuRD recruitment integrates with CtBP and p300 mechanisms unclear\", \"Other NuRD-dependent targets not mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Established SUMOylation and additional microRNAs as layers tuning FOG-2 abundance and activity, with SUMOylation attenuating GATA-4 interaction and repression.\",\n      \"evidence\": \"SUMO-site mutagenesis, SENP de-SUMOylation, reporter assays and co-IP; miR-17-92 3′UTR reporter and rescue\",\n      \"pmids\": [\"23226341\", \"22267003\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo physiological role of FOG-2 SUMOylation not tested\", \"Upstream signals controlling FOG-2 SUMOylation unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected FOG2 PI3K inhibition to disease physiology, showing TGF-β/miR-200b/c suppression of FOG2 drives Akt/ERK activation and mesangial hypertrophy.\",\n      \"evidence\": \"siRNA knockdown, miR-200b/c mimic/inhibitor, and pathway western blots in mesangial cells\",\n      \"pmids\": [\"23788640\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo renal validation not performed\", \"Whether nuclear FOG2 functions contribute not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extended FOG2 partnerships beyond GATA4 to AML1 (in a leukemic fusion) and to the co-repressor Art27 and NKX2.5, broadening its co-regulatory network.\",\n      \"evidence\": \"Fusion gene characterization with co-IP/reporter assays; yeast two-hybrid validated by co-IP and reporters\",\n      \"pmids\": [\"15705784\", \"24743694\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"AML1-FOG2 is a disease-specific fusion, not endogenous FOG2 function\", \"Art27 interaction lacks in vivo validation\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Refined gonadal roles by conditional ablation, revealing non-overlapping essential functions for FOG2 and GATA4 in testis development with FOG2 loss causing sex reversal.\",\n      \"evidence\": \"Sf1Cre conditional knockouts with gonadal gene expression and histology\",\n      \"pmids\": [\"21385577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic basis of FOG2-specific male-pathway block not fully defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified GATA4-FOG2 repression of Dkk1 and β-catenin signaling as a node in ovarian versus testis fate, deepening the developmental logic of sex determination.\",\n      \"evidence\": \"Double-mutant genetic epistasis (Fog2/Dkk1, Gata4ki/Dkk1) and gonadal β-catenin conditional KO\",\n      \"pmids\": [\"18927154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin binding of GATA4-FOG2 at Dkk1 not shown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Broadened FOG2 function to neocortical neuron differentiation and hepatic metabolism, showing it controls corticothalamic projection neuron identity via Ctip2 and regulates insulin sensitivity and hepatic triglyceride through PPARα.\",\n      \"evidence\": \"Conditional CThPN knockout with axonal tracing; adenoviral and liver-specific KO models with PPARα rescue\",\n      \"pmids\": [\"27321927\", \"27207553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether neuronal/hepatic roles depend on GATA partners or PI3K inhibition unresolved\", \"Transcriptional targets in liver beyond PPARα undefined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined the genomic mechanism of adult atrial rhythm control, showing FOG2 antagonizes a TBX5/GATA4 atrial network at co-bound loci including a SERCA2 enhancer, with genetic epistasis rescuing TBX5-driven arrhythmia.\",\n      \"evidence\": \"Transgenic overexpression, in vivo/cellular electrophysiology, calcium imaging, ChIP/genomic analysis, and Tbx5+/-;Zfpm2+/- epistasis\",\n      \"pmids\": [\"38189150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full TBX5/GATA4 co-regulated atrial target set not exhaustively defined\", \"Cause of FOG2 upregulation in human heart failure unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How FOG2 integrates its distinct molecular modes — GATA co-repression via NuRD/CtBP, coactivator competition, SUMO-tuned activity, and cytoplasmic PI3K inhibition — into tissue-specific outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of FOG2 in any complex\", \"Spatial control distinguishing nuclear transcriptional from cytoplasmic PI3K functions not established\", \"Genome-wide direct target catalogs across tissues incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 4, 10, 11, 24, 30]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [17, 11]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 24, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 4, 24, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [2, 3, 5, 12, 28]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [17, 23]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [24, 1]}\n    ],\n    \"complexes\": [\"NuRD complex\"],\n    \"partners\": [\"GATA4\", \"CtBP2\", \"p300\", \"TBX5\", \"PIK3R1\", \"THRA\", \"RXRA\", \"NKX2-5\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}